Santori & Peters Inc’s NeoGenomics NEO Stock Holding History

Santori & Peters Inc’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-385	Closed	-$2K	–	366
2017 Q4	$2K	Buy	+385	New	+$3.55K	﹤0.01%	564

Other funds holding NEO

General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

FPC

Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return

Santori & Peters Inc's NEO Position: Q1 2018 in Review

Santori & Peters Inc sold out of NeoGenomics (NEO) in Q1 2018, closing a stake of 385 shares — an estimated $2K sold.

Santori & Peters Inc first reported a position in NEO in Q4 2017 and held it in 1 quarter. The position peaked at $2K in Q4 2017. 137 funds tracked by Wall St. Rank hold NEO as of Q1 2018.

Santori & Peters Inc reported no remaining NeoGenomics position as of Q1 2018 after selling out during the quarter.
Santori & Peters Inc sold 385 NeoGenomics shares in Q1 2018, an estimated $2K.
Santori & Peters Inc first reported a position in NeoGenomics in Q4 2017 and held it in 1 quarter.
Santori & Peters Inc's NeoGenomics position peaked at $2K in Q4 2017.
137 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2018.

Based on Santori & Peters Inc's 13F filing for Q1 2018, filed 16 Apr 2018.